Fragasso Group Inc. Abbott Laboratories Transaction History

Fragasso Group Inc.

$1.24 Billion
Q3 2024

A detailed history of Fragasso Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Fragasso Group Inc. holds 5,994 shares of ABT stock, worth $705,194. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,994

Previous 6,023 0.48%

Holding current value

$705,194

Previous $625,000 9.28%

% of portfolio

0.06%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$100.07 - $118.13 $2,902 - $3,425	-29 Reduced 0.48%	5,994 $683,000
Q2 2024 Jul 08, 2024	BUY	$100.73 - $112.44 $23,671 - $26,423	235 Added 4.06%	6,023 $625,000
Q1 2024 Apr 10, 2024	BUY	$109.52 - $120.96 $17,851 - $19,716	163 Added 2.9%	5,788 $657,000
Q4 2023 Jan 08, 2024	BUY	$90.19 - $110.4 $15,422 - $18,878	171 Added 3.14%	5,625 $619,000
Q3 2023 Dec 06, 2023	SELL	$95.53 - $114.62 $382 - $458	-4 Reduced 0.07%	5,454 $528,000
Q2 2023 Jul 10, 2023	SELL	$100.78 - $112.29 $7,356 - $8,197	-73 Reduced 1.32%	5,458 $595,000
Q1 2023 Apr 13, 2023	BUY	$96.86 - $114.01 $12,010 - $14,137	124 Added 2.29%	5,531 $560,000
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $513,989 - $602,988	-5,407 Closed	0 $0
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $5,323 - $6,245	-56 Reduced 1.03%	5,407 $0
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $19,545 - $22,630	202 Added 3.84%	5,463 $529,000
Q2 2022 Aug 30, 2022	BUY	$102.07 - $123.37 $1,837 - $2,220	18 Added 0.34%	5,261 $572,000
Q1 2022 Apr 06, 2022	BUY	$114.02 - $139.04 $1,710 - $2,085	15 Added 0.29%	5,243 $621,000
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $79,253 - $97,041	-686 Reduced 11.6%	5,228 $736,000
Q3 2021 Oct 08, 2021	BUY	$116.66 - $129.06 $69,179 - $76,532	593 Added 11.14%	5,914 $699,000
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $2,221 - $2,615	21 Added 0.4%	5,321 $617,000
Q1 2021 May 27, 2021	BUY	$108.84 - $128.23 $9,033 - $10,643	83 Added 1.59%	5,300 $635,000
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $1,260 - $1,373	12 Added 0.23%	5,217 $571,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $1,374 - $1,669	15 Added 0.29%	5,205 $566,000
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $1,301 - $1,666	17 Added 0.33%	5,190 $525,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $3,266 - $4,776	-52 Reduced 1.0%	5,173 $408,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $6,673 - $7,429	85 Added 1.65%	5,225 $454,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $1,309 - $1,419	16 Added 0.31%	5,140 $430,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $1,311 - $1,530	18 Added 0.35%	5,124 $431,000
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $1,191 - $1,441	18 Added 0.35%	5,106 $408,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $1,048 - $1,188	16 Added 0.32%	5,088 $368,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $25,418 - $30,664	418 Added 8.98%	5,072 $357,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $3,094 - $3,499	55 Added 1.2%	4,654 $279,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $221,027 - $246,690	4,599	4,599 $245,000

Others Institutions Holding ABT

# of Institutions

3,173

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account

Fragasso Group Inc. Abbott Laboratories Transaction History